Mashukur Rahman/LinkedIn
Feb 8, 2026, 14:09
Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
Mashukur Rahman, Resident Doctor at Bangladesh Medical University, Medical Officer at Directorate General of Health Services, shared a post on LinkedIn.
“Many doctors still think statins are only for high LDL cholesterol.
But the new ESC dyslipidemia updates suggest a bigger role.
Why this matters now:
- Statins may help protect the heart in some cancer patients.
Some chemotherapy drugs like anthracyclines can cause heart failure years later. Preventive statin use is getting stronger support. - We are moving from treating numbers to treating overall risk.
Risk builds silently, even when LDL is not very high.
In real life, we often wait for LDL to cross a ‘clear cutoff.’
But by then, damage may already be starting.
If statins are becoming broader heart-protection drugs — when should we start them in borderline-risk patients?”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers